Notes for P&L
Note 1 Critical accounting policies
Note 2 Revenues
Note 3 Operating segments
Note 4 Financial risk and risk management
Note 5 Other operating income
Note 6 Other operating expenses
Note 7 Employees, personnel costs and remuneration of senior executives
Note 8 Fees and reimbursement of auditors
Note 9 Operating expenses by cost class
Note 10 Development expenditure
Note 11 Financial income/expense
Note 12 Taxes
Note 13 Shareholders’ equity and number of shares
Note 14 Intangible assets
Note 15 Property, plant and equipment
Note 16 Inventories
Note 17 Financial assets
Note 18 Prepaid expenses and deferred income
Note 19 Cash and cash equivalents
Note 20 Financial liabilities
Note 21 Other current liabilities
Note 22 Accrued expenses and deferred income
Note 23 Financial risks and risk management
Note 24 Customers
Note 25 Leases
Note 26 Statement of Cash Flows
Note 27 Post balance sheet date events
Note 10 Development expenditure
The Group’s expenses for technology development and patents in 2024 amounted to SEK 120.8 M (164.1) of which SEK 11.8 M (46.8) or 10 percent (29%) was capitalized in the consolidated statement of financial position and the remaining SEK 109.0 M (117.3) was expensed.